Company: KWIK
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001683168-25-002055
Chunk: 91

Company: KwikClick, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 91
---
, including the market
acceptance of our products and services; the levels of promotion and advertising that will be required to launch our new products and
services and achieve and maintain a competitive position in the marketplace; our business, product, capital expenditures and technology
plans, and product and technology roadmaps; technological advances; our competitors’ responses to our products and services; our
pursuit of mergers and acquisitions; and our relationships with our customers.

We cannot provide assurance that we will be able to
raise the needed capital on commercially acceptable terms, or at all. Delay, disruption, or failure to obtain sufficient financing may
result in the delay or failure of our business plans. Our inability to raise sufficient capital on commercially acceptable terms, or at
all, could have a material adverse effect on our Company and the trading price of our common stock.

Our common stock is expected to be subject to significant
dilution as a result of fund raising and issuance of employee, director and consultant incentive shares

We intend to raise money and incentivize employees,
directors and consultants by issuing shares of our common stock.  We are likely to issue significant numbers of shares of our common
stock, or options, warrants, or other securities convertible into shares of our common stock, as a portion of the consideration for acquisitions.
We are also likely to issue significant numbers of shares, options and/or warrants to our officers and directors. Such transactions may
significantly increase the number of outstanding shares of our common stock and may be highly dilutive to our existing Stockholders. In
addition, the securities that we issue may have rights, preferences or privileges senior to those of the holders of our outstanding common
stock. If millions of options and warrants were to be exercised, the number of outstanding shares of our common stock would increase significantly.
 All of the foregoing stock issuance and resulting dilution of investor shares could have a material adverse and downward effect
on our Company and the trading price of our common stock.

Raising capital by selling our common stock is
difficult to accomplish

Selling equity can be difficult to accomplish for
companies that are not traded on national exchanges such as Nasdaq or New York Stock Exchange, particularly for companies in the development
stage. Our common stock is only traded on the over the counter “OTC” market. This difficulty caused by our OTC market status
may make future acquisitions either unlikely or too difficult and expensive. This could materially adversely affect our Company and the
trading price of our